Overview

Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia

Status:
Recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
This study plans to learn more about the effects of levetiracetam (LEV) on brain activity and cognition in schizophrenia and schizoaffective disorder. Levetiracetam is an anti-seizure drug, also called an anticonvulsant.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
VA Office of Research and Development
Treatments:
Etiracetam
Levetiracetam
Piracetam